GPC Biotech (GPCBY) 6-K Current report (foreign)

Exhibit 1

GPC BIOTECH’S MISSION IS TO DISCOVER,

DEVELOP AND COMMERCIALIZE NEW ANTICANCER

DRUGS.

Perspectives of the principal investigators on the satraplatin SPARC Phase 3 trial conducted in

patients with hormone-refractory prostate cancer who have undergone prior chemotherapy.

	Content
2	SPARC Trial
10	Key Events
12	Letter to Shareholders
20	Satraplatin
24	Drug Discovery and Development
26	GPC Biotech Stock
28	Consolidated Financial Statements
69	Corporate Governance
76	Report of the Supervisory Board
78	Executive Committee
80	Glossary
83	Trademarks
84	Financial Calendar and Contacts

Consolidated Financial Statements (U.S. GAAP)
	Content
29	Independent Auditor’s Report
30	Management Report
40	Consolidated Balance Sheet
41	Consolidated Statement of Operations
42	Consolidated Statement of Cash Flows
43	Consolidated Statement of Changes in Shareholders’ Equity
44	Notes to Consolidated Financial Statements